About Alfresa Group
Investor Information
 Corporate Social
 Responsibility

Sitemap
 
HOME > News Release



2010/07/01Notice Concerning Transfer of Manufacturing and Marketing of Tofranil Tablets Used for the Treatment of Depression and Depressive Disorders As Well As Enuresis
2010/05/11Consolidated Financial Statements for the Fiscal Year Ended March 31, 2010
2010/05/11Announcement of Basic Agreement on Management Integration between Alfresa Holdings and TAMPEI NAKATA
2010/05/11Announcement of "10-12 Medium-term Management Plan Advancement and Expansion - Next Stageh
2010/04/26Notice Concerning Revision of Financial Forecasts
2010/03/26Notice of Business Alliance Regarding Wholesaling of Foods, Daily Necessities and Over-the-Counter Drugs, etc.
2010/02/04Consolidated Financial Statements for the Third Quarter of the Fiscal Year Ending March 31, 2010
2010/02/04Notice Concerning Purchase of Treasury Stock from a Shareholder Opposed to Simplified Stock Exchange with Consolidated Subsidiaries
2009/12/22Conclusion of Business Transfer Contract for CS YAKUHIN to Take Over Some OTC Drugs Wholesaling Business from TOMITA Healthcare
2009/12/22Notice of Acquisition of Rating
2009/11/13Notice Concerning Operation of a Formulation Building of a Subsidiary
2009/11/04Notice Concerning Conversion of Alfresa Nikken Sangyo Corporation into a Wholly-owned Subsidiary through Simplified Stock Exchange
2009/11/04Notice Concerning Conversion of Ando Co., Ltd. into a Wholly-owned Subsidiary through Simplified Stock Exchange
2009/11/04Consolidated Financial Statements for the Second Quarter of the Fiscal Year Ending March 31, 2010
2009/10/26Notice Concerning Revision of Financial Forecasts
2009/10/01Conclusion of Agreement on Business Alliance Regarding Wholesaling of Foods and Over-the-Counter Drugs, etc.
2009/09/18Notice on Determination of Number of Shares to be Issued by Way of Third-Party Allotment
2009/09/09Notice on Determination of Issue Price, Selling Price and Other Matters
2009/08/27Notice on Issuance of New Shares and Secondary Offering of Shares
2009/08/04Consolidated Financial Statements for the First Quarter of the Fiscal Year Ending March 31, 2010
2009/07/27Notice of Construction of Head Office and Distribution Center by a Subsidiary
2009/07/27Conclusion of Business Transfer Contract between Consolidated Subsidiaries
2009/07/10Change of Schedule for CS YAKUHIN to Take Over Some OTC Drugs Wholesaling Business from TOMITA Healthcare
2009/05/12Consolidated Financial Statements for the Fiscal Year Ended March 31, 2009
2009/04/27Conclusion of Basic Agreement for CS YAKUHIN to Take Over Some OTC Drugs Wholesaling Business from TOMITA Healthcare
2009/03/24Notice Concerning Revision of Consolidated Financial Forecasts for the Year Ending March 31, 2009
2009/03/24Notice Concerning Revision of Dividend Forecasts for the Year Ending March 31, 2009
2009/02/05Consolidated Financial Statements for the Third Quarter of the Fiscal Year Ending March 31, 2009
2009/02/05Notice of Personnel Changes of Representative Directors
2009/02/03Notice of Business Alliance to Create New Businesses in the Food and Health Field
2009/01/09Notice on Dissolution of Basic Agreement for Merger between Mediceo Paltac Holdings and Alfresa Holdings
2008/12/15Alfresa Pharma Corporation Releases Anti-seizure NOBELBAR 250mg for Injection
2008/12/02Notice on Change of Date for Conclusion of Merger Agreement between Mediceo Paltac Holdings and Alfresa Holdings
2008/11/26Notice of Agreement to Transfer Manufacturing and Marketing of Allergy Therapeutic Agent Pemilaston to Alfresa Pharma Corporation
2008/11/05Consolidated Financial Statements for the Second Quarter of the Fiscal Year Ending March 31, 2009
2008/11/05Revision of Consolidated Financial Projections for the Year Ending March 31, 2009
2008/10/24Notice Concerning Business Partnership in the Wholesaling of Over-the-Counter Drugs and Other Products
2008/10/10Announcement of Agreement on Merger between Mediceo Paltac Holdings and Alfresa Holdings
2008/09/24Notice Concerning Business Partnership between Alfresa Holdings Corporation and MEDICAL SYSTEM NETWORK Co., Ltd.
2008/09/24Notice Concerning Acquisition of Shares in Pharmaholdings Co., Ltd.
2008/08/04Consolidated Financial Statements for the First Quarter of the Fiscal Year Ending March 31, 2009
2008/07/28Notice of Conclusion of Partnership Agreement Concerning Marketing and Development between Alfresa Pharma Corporation and Nobelpharma Co., Ltd.
2008/05/30Alfresa Holdings Announces Application for Approval of Additional Indications for Sleep Disorder Drug Modiodal 100mg Tablets
2008/05/12Consolidated Financial Statements for the Fiscal Year Ended March 31, 2008
2008/05/12Notice of Dividends of Surplus
2008/05/12Conclusion of Business Transfer Contract for Over-the-Counter Drugs Wholesaling Business
2008/04/25Alfresa Holdings to Subscribe to a Third-Party Allotment of New Shares in TAMPEI NAKATA
2008/03/26Notice Concerning Acquisition of Shares of APOLLO MEDICAL HOLDINGS INC and Thereby Making APOLLO MEDICAL HOLDINGS a Subsidiary
2008/02/27Conclusion of Basic Agreement on Capital and Business Alliance
2008/02/07Notice of Operation of Distribution Center by a Subsidiary
2008/02/05Consolidated Financial Statements for the Third Quarter of the Fiscal Year Ending March 31, 2008
2008/01/31Notice of Construction of Distribution Center by a Subsidiary
2007/11/12Consolidated Financial Statements for the Interim Period of the Fiscal Year Ending March 31, 2008
2007/11/12Conclusion of Agreement to Establish a Structure for the Self-Medication Business
2007/10/24Notice of Construction of Distribution Center by a Subsidiary
2007/09/28Establishment of System Subsidiary
2007/08/06Notice of Conclusion of Stock Exchange Agreement between Alfresa Holdings Corporation and CS YAKUHIN CO., LTD.
2007/08/06Consolidated Financial Statements for the First Quarter of the Fiscal Year Ending March 31, 2008
2007/07/25Notice of Conclusion of Stock Exchange Agreement between Alfresa Holdings Corporation and RYUYAKU CO., LTD.
2007/05/14Consolidated Financial Statements for the Fiscal Year Ended March 31, 2007
2007/02/05Consolidated Financial Statements for the Third Quarter of the Fiscal Year Ending March 31, 2007
2006/11/13Consolidated Financial Statements for the Interim Period of the Fiscal Year Ending March 31, 2007
2006/08/09Consolidated Financial Statements for the First Quarter of the Fiscal Year Ending March 31, 2007
2006/05/12Consolidated Financial Statements for the Fiscal Year Ended March 31, 2006
2006/02/10Consolidated Financial Statements for the Third Quarter of the Fiscal Year Ending March 31, 2006
2005/11/16Consolidated Financial Statements for the Interim Period of the Fiscal Year Ending March 31, 2006
2005/08/09Consolidated Financial Statements for the First Quarter of the Fiscal Year Ending March 31, 2006
2005/05/12Announcement of Stock Exchange Agreement with SEIWA SANGYO
2005/05/12Consolidated Financial Statements for the Fiscal Year Ended March 31, 2005
2005/02/14Announcement of Basic Agreement on Transfer of Over-the-counter Drugs Business
2005/02/10Consolidated Financial Statements for the Third Quarter of the Fiscal Year Ending March 31, 2005
2004/11/15Announcement on Buyback of Treasury Stocks through ToSTNeT-2
2004/11/15Announcement on Acquisition of Treasury Stocks from Subsidiaries
2004/11/11Announcement of Call for Voluntary Retirees
2004/11/11Announcement of Basic Agreement with NIKKEN SANGYO CO., LTD.
2004/11/11Announcement of Basic Agreement on Management Integration with Four Companies in Shikoku Area
2004/11/11Consolidated Financial Statements for the Interim Period of the Fiscal Year Ending March 31, 2005
2004/10/05Alfresa Announces Partial Amendments to Financial Forecast for the Interim Period of the Fiscal Year Ending March 31, 2005
2004/10/01Announcement of the Conclusion of Business Cooperation Agreement with Meisho Co., Ltd.
2004/09/16Announcement on Partial Acquisition of Business from Matsuda Medical Co., Ltd.
2004/09/16Announcement of Basic Agreement on the Establishment of a Joint Venture Company
2004/09/03Alfresa Announces the Conclusion of Business Cooperation Agreement
2004/08/10Consolidated Financial Statements for the First Quarter of the Fiscal Year Ending March 31, 2005
2004/07/08Alfresa Announces the Conclusion of Corporate Separation Agreement among Subsidiaries
2004/05/18Consolidated Financial Statements for the Year Ended March 31, 2004
2004/05/06Alfresa Announces Restructuring of Taishodo Co., Ltd. as a Wholly Owned Subsidiary through Stock Transfer
2004/04/28Announcement of Dividend Increase for Fiscal Year Ended in March 2004
2004/04/06Alfresa Group's Appointment of New Management and Reorganization by Corporate Division Announced
2004/04/01Acquisition Notice of Shares of DAIWA Pharmaceutical Wholesalers Co., Ltd. to Make It a Subsidiary
2004/04/01Acquisition Notice of Shares of Odashima Limited
2004/03/25Alfresa Announces five-way Corporate Alliance in Over-the-counter Drugs Sector
2004/02/10Fukujin Co., Ltd. is to acquire shares in Odashima Limited
2004/02/10Consolidated Earnings Summary for 9 Months of the Fiscal Year Ending March 2004
2004/01/20Fukujin Co., Ltd. is to acquire shares in DAIWA Pharmaceutical Wholesalers Co., Ltd.
2003/11/19Consolidated Business Results for the Interim Period of Fiscal Year ending March 2004
2003/10/14Announcement of Basic Agreement on Management Integration
2003/09/18Announcement of Partial Amendments to Financial Forecast of Alfresa Holdings Corporation for Fiscal Year Ending March 2004
2003/09/10Structure and Functions of Alfresa Holdings Corporation
2003/09/10Middle-term Business Plan of Alfresa Holdings Corporation
2003/09/10Alfresa Holdings Corporation Medium-Term Management Plan
2003/09/10Financial Forecast of Alfresa Holdings Corporation for Fiscal Year Ending March 2004


 
   
 Copyright (C) 2004 Alfresa Holdings Corporation, All Rights Reserved.
 
It is prohibited to reprint or convert any articles published on this website without permission.
This website complies with HTML 4.0. It is also recommended to use the latest version of Internet Explorer or Netscape for browsing.